HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

perindopril drug combination indapamide

an antihypertensive
Also Known As:
indapamide, perindopril drug combination; Preterax; S 5590; S5590
Networked: 80 relevant articles (4 outcomes, 69 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Chalmers, John: 27 articles (10/2015 - 01/2003)
2. Woodward, Mark: 23 articles (10/2015 - 04/2009)
3. Poulter, Neil: 19 articles (01/2015 - 04/2009)
4. Patel, Anushka: 19 articles (12/2014 - 08/2006)
5. Zoungas, Sophia: 18 articles (10/2015 - 08/2009)
6. ADVANCE Collaborative Group: 15 articles (10/2015 - 01/2007)
7. Williams, Bryan: 14 articles (10/2015 - 04/2009)
8. Hamet, Pavel: 14 articles (01/2015 - 04/2009)
9. Neal, Bruce: 13 articles (10/2015 - 04/2009)
10. Mancia, Giuseppe: 13 articles (10/2014 - 04/2009)

Related Diseases

1. Vascular Diseases (Vascular Disease)
2. Hypertension (High Blood Pressure)
3. Neoplasms (Cancer)
4. Cardiovascular Diseases (Cardiovascular Disease)
11/01/2010 - "Oral disease and subsequent cardiovascular disease in people with type 2 diabetes: a prospective cohort study based on the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial."
11/01/2009 - "Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial."
06/01/2009 - "Cardiovascular disease is the predominant cause of death in diabetic patients, and reducing the risk of cardiovascular disease in diabetics has recently been the focus of several highly publicized large trials, including ACCORD (Action To Control Cardiovascular Risk in Diabetes), ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation), and VADT (Veterans Affairs Diabetes Trial). "
11/30/2010 - "Erectile dysfunction and later cardiovascular disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation) trial."
08/01/2003 - "The Action in Diabetes and Vascular disease: PreterAx and DiamicroN modified release Controlled Evaluation (ADVANCE) study is discussed as a trial designed to resemble clinical practice that promises to provide answers concerning the value conferred by blood pressure-lowering therapy and intensive glucose control therapy in type 2 diabetes patients at high risk for cardiovascular disease."
5. Type 2 Diabetes Mellitus (MODY)
08/01/2009 - "In conclusion, SBP and PP are the 2 best and DBP is the least effective determinant of the risk of major cardiovascular outcomes in the relatively old patients with type 2 diabetes mellitus participating in the Action in Diabetes and Vascular Disease: Preterax and Diamicron-Modified Release Controlled Evaluation Study. "
01/01/2015 - "Predicting the effects of blood pressure-lowering treatment on major cardiovascular events for individual patients with type 2 diabetes mellitus: results from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation."
09/17/2013 - "The Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) was a factorial randomized controlled trial of blood pressure lowering and blood glucose control in patients with type 2 diabetes mellitus. "
06/01/2007 - "ADVANCE (Action in Diabetes and Vascular Disease - PreterAx and DiamicroN MR Controlled Evaluation) is a large-scale clinical trial designed to investigate the benefits of blood pressure lowering and intensive glucose control in patients with type 2 diabetes mellitus. "
09/15/2010 - "ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES (ACCORD), THE ACTION IN DIABETES AND VASCULAR DISEASE: Preterax and Diamicron Modified Release Controlled Evaluation and the Veterans Affairs Diabetes Trial were designed to study whether older patients with type 2 diabetes mellitus could reduce the risk of heart attacks and stroke and thereby prolong their lives by maintaining their blood glucose levels at near-healthy levels but failed to demonstrate the hoped-for benefit. "

Related Drugs and Biologics

1. Gliclazide (Diamicron)
2. Glucose (Dextrose)
3. Perindopril
4. Indapamide
5. rosiglitazone (Avandia)
6. pioglitazone (Actos)
7. Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)
8. Blood Glucose (Blood Sugar)
9. Ramipril (Altace)
10. Retinaldehyde (Retinal)